Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians
Observ-MTEV
1 other identifier
observational
383
1 country
1
Brief Summary
In France, venous thromboembolic (VTE) disease is usually managed by vascular medicine physicians (VMP). The national OPTIMEV study, conducted more than 12 years ago among VMP practicing in hospital and in the community described the management of VTE in routine clinical practice. Since then a large number of practice changing studies have been published. This includes trials that have validated the use of direct oral anticoagulants (DOAC), the new standard of care of VTE, as per new national and international guidelines. Management of VTE in 2019 appears to be significantly different from the one that prevailed more than 10 years ago when the last national survey was conducted. It is therefore important to have an update on the routine clinical practice management of VTE by VMP. In this perspective the investigators aim to conduct a national survey among VMP practicing in France
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 21, 2019
CompletedFirst Submitted
Initial submission to the registry
February 13, 2020
CompletedFirst Posted
Study publicly available on registry
February 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedJuly 12, 2023
July 1, 2023
3.9 years
February 13, 2020
July 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Inter-practician variability of clinical care of venous thromboembolic in routine clinical practice
The variation in venous thromboembolic management in routine clinical practice is assessed by analysing the management of the 5 consecutive acute venous thromboembolic patients reported by each participating physician
up to 3 months after inclusion
Secondary Outcomes (3)
Inter-practician variability of clinical care of venous thromboembolic according to patient age
up to 6 months after inclusion
Inter-practician variability of clinical care of venous thromboembolic according to patient body weight
up to 6 months after inclusion
Inter-practician variability of clinical care of venous thromboembolic according to patient bleeding risk
up to 6 months after inclusion
Study Arms (2)
VMP members of the SFMV
VMP (vascular medicine physicians) members of the SFMV (French Society of Vascular Medicine )
VMP registered as willing to do medical research
VMP (vascular medicine physicians) registered as willing to do medical research
Eligibility Criteria
Vascular medicine physicians (VMP) practicing in the hospital and in the community settings. Participating VMP will prospectively collect data on the management of incident venous thromboembolic (VTE) disease cases. After that, vascular medicine physicians will answer a phone questionnaire on their general VTE management
You may qualify if:
- vascular medicine physicians who are active members of the SFMV (French Society of Vascular Medicine)
- vascular medicine physicians registered as willing to do medical research
You may not qualify if:
- vascular medicine physicians who refuse to provide consent
- vascular medicine physicians who are retired
- non-practicing vascular medicine physicians
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens
Amiens, 80480, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Simon Soudet, MD
CHU Amiens
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 13, 2020
First Posted
February 17, 2020
Study Start
August 21, 2019
Primary Completion
July 1, 2023
Study Completion
July 1, 2023
Last Updated
July 12, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share